CGEM- Cullinan Therapeutics, Inc.

Name: Cullinan Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Cullinan Therapeutics, Inc. (CGEM) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 18 sells. CGEM is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Lynx1 Capital Management LP	8.96M	$122.80M	-
CEO	Ahmed Nadim	420.7K	$5.76M	-
Other	Jones Jeffrey Alan	169.5K	$2.32M	-
Other	Sumer Jacquelyn L	135.4K	$1.86M	-
Other	Michaelson Jennifer	132.6K	$1.82M	-

Activity

Buys and sells only

Transactions

10 filings · page 11

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 25, 2021	Gadicke Ansbert85	Director, 10% Owner	Sell	120,592	$29.29	$3,531,819.71	-0.5%	-28.9%	-49.8%
Aug 23, 2021	Zawel Leigh82	See Remarks	Sell	28,118	$29.00	$815,422.00	-23.1%	-36.6%	-54.9%
Aug 18, 2021	Michaelson Jennifer65	See Remarks	Sale+OE	4,000	$27.66	$110,648.09	-7.8%	-23.5%	-50.8%
Aug 11, 2021	Ubs Oncology Impact Fund L.P.89	10% Owner	Sell	2,510	$29.05	$72,915.50	-	-21.8%	-53.9%
Aug 11, 2021	Gadicke Ansbert85	Director, 10% Owner	Sell	2,857	$29.05	$82,995.85	-	-21.8%	-53.9%
Aug 10, 2021	Baeuerle Patrick	See Remarks	Sale+OE	11,000	$27.00	$297,000.00	-100%	-17.3%	-51.1%
Aug 10, 2021	Zawel Leigh82	See Remarks	Sell	28,118	$26.77	$752,850.35	-4.3%	-17.3%	-51.1%
Jan 12, 2021	Jovan-Embiricos Morana87	Director, 10% Owner	Buy	200,000	$21.00	$4,200,000.00	+38.0%	-	-
Jan 12, 2021	Gadicke Ansbert85	Director, 10% Owner	Buy	300,000	$21.00	$6,300,000.00	+3.9%	-	-
Jan 12, 2021	Ubs Oncology Impact Fund L.P.89	10% Owner	Buy	300,000	$21.00	$6,300,000.00	+3.9%	-	-

← PrevPage 11Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC